94316-7

SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection

Active

Term Description

Qualitative detection of nucleic acids within the nucleoprotein (N) gene of SARS coronavirus 2 (SARS-CoV-2) in various specimens, including lower & upper respiratory, serum, stool or urine, by nucleic acid amplification with probe-based detection. Various assays have been developed that contain primer-probe sets targeting N gene. [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] If using the Centers for Disease Control and Prevention (CDC) SARS-CoV-2 (2019-nCoV) assay, use the codes specific for the target 1 (N1) [LOINC: 94307-6] and target 2 (N2) [LOINC: 94308-4] primer-probe sets for the N gene developed by CDC.[CDC: coronavirus/COVID-19/lab/] The N3 target in the CDC assay is specific for SARS-like Coronavirus [LOINC: 94310-0].
Source: Regenstrief LOINC

Part Description

LP417599-0 SARS coronavirus 2 N gene
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC: coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] Source: Regenstrief LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing
Package Insert	World Health Organization (WHO)Copyright Copyright © 2001 World Health Organization.	Diagnostic detection of 2019-nCoV by real-time RT-PCR

Fully-Specified Name

Component: SARS coronavirus 2 N gene
Property: PrThr
Time: Pt
System: XXX
Scale: Ord
Method: Probe.amp.tar

Additional Names

Short Name: SARS-CoV-2 N gene Spec Ql NAA+probe
Display Name: SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Specimen)
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) N gene, Specimen

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINC	Name	R/O/C	Example UCUM Units
81959-9	Public health laboratory ask at order entry panel
Indent81744-5	Submitter's laboratory test method [Type] in Specimen
Indent81658-7	Suspected organism [Identifier] in Specimen
Indent86952-9	Preliminary testing done Specimen
Indent86953-7	Preliminary testing result Specimen
Indent86955-2	Preliminary testing affected submission for further testing Specimen
Indent95417-2	Whether this is the patient's first test for condition of interest
Indent95418-0	Whether patient is employed in a healthcare setting
Indent95419-8	Whether the patient has symptoms related to condition of interest
Indent11368-8	Illness or injury onset date and time	C
Indent77974-4	Whether the patient was hospitalized for condition of interest
Indent95420-6	Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4	Whether patient resides in a congregate care setting
Indent82810-3	Pregnancy status	C
Indent30525-0	Age		a

Example Answer List: LL744-4

Source: Regenstrief Institute

Answer	Code	Score	Answer ID
Detected			LA11882-0
Not detected			LA11883-8

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
94306-8	SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection

Member of these Groups Get Info

LOINC Group	Group Name
LG51017-8	SARSCoV2 detection
LG51019-4	SARSCoV2 molecular detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 N-Gen:Nachweis oder Schwellenwert:Zeitpunkt:XXX:Ordinal:Zielfragmentamplifikation mit Sondendetektion
es-ES	Spanish (Spain)	Gen N de SARS-CoV-2 (COVID-19):PrThr:Punto temporal:XXX:Ord:Sonda con amplificación dirigida
es-MX	Spanish (Mexico)	Gen del coronavirus 2 N del SARS:Presencia o umbral:Punto temporal:XXX:Ordinal:Amplificación de ácidos nucleicos con detección de sonda
fr-FR	French (France)	Coronavirus SARS-CoV-2 gène N:Présence/Seuil:Ponctuel:Milieux divers:Qualitatif:PCR amplification de cible
fr-CA	French (Canada)	Gène N du coronavirus 2 du SRAS:Présence-Seuil:Temps ponctuel:XXX:Ordinal:Sonde avec amplification de la cible
it-IT	Italian (Italy)	SARS coronavirus 2, gene N:PrThr:Pt:XXX:Ord:Sonda.amp.tar Synonyms: Coronavirus della SARS Gene N di SARS-CoV-2 (COVID-19) Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NL	Dutch (Netherlands)	SARS-CoV-2 N-gen:aanwezigheid:moment:XXX:ordinaal:probe-detectie Synonyms: evere acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19 probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
zh-CN	Chinese (China)	SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ II N 型 SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型借助扩增的探针方法;借助扩增的探针法;探针法.扩增借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）扩增型扩增性时刻;随机;随意;瞬间经过扩增的脱氧核糖核酸探针遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94316-7

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.